Suppr超能文献

蛋白尿改善可能降低心房颤动风险:一项基于全国人群的队列研究

Improved Proteinuria May Attenuate the Risk of Atrial Fibrillation: A Nationwide Population-Based Cohort Study.

作者信息

Chang Yoonkyung, Kang Min Kyoung, Song Tae-Jin

机构信息

Department of Neurology, Mokdong Hospital, Ewha Womans University College of Medicine, Seoul 07985, Republic of Korea.

Department of Neurology, Seoul Hospital, Ewha Womans University College of Medicine, Seoul 07804, Republic of Korea.

出版信息

J Clin Med. 2024 Aug 8;13(16):4648. doi: 10.3390/jcm13164648.

Abstract

: Proteinuria is documented as a risk factor for atrial fibrillation (AF) and can manifest in either reversible or continued forms. Our objective was to examine the relationship between the change in status for proteinuria and the risk of AF in a longitudinal cohort study on the general population nationwide. : We included participants ( = 1,708,103) who underwent repetitive health examinations. The presence of proteinuria was determined by dipstick urinalysis results. The outcome was the occurrence of AF (International Classification of Diseases-10 code: I48). : All included participants, 1,666,111 (97.5%), 17,659 (1.0%), 19,696 (1.2%), and 4637 (0.3%), were categorized into groups of proteinuria-free, improved, progressed, and persistent, respectively. During a median follow-up of 14.5 years, 41,190 (2.4%) cases of AF occurred. In the multivariable analysis, the risk of AF was increased as the initial severity was more severe in the proteinuria-improved and proteinuria-persistent groups ( for trend < 0.001). In a further pairwise comparison, the proteinuria-improved group had a relatively lower risk of AF compared to the proteinuria-persistent group (HR: 0.751, 95% CI: 0.652-0.865, < 0.001). : Our study showed that the risk of AF can change according to alterations in proteinuria status. Notably, recovering from proteinuria can also be considered a modifiable risk factor for AF.

摘要

蛋白尿被证明是心房颤动(AF)的一个危险因素,可表现为可逆或持续形式。我们的目的是在一项针对全国普通人群的纵向队列研究中,研究蛋白尿状态变化与AF风险之间的关系。:我们纳入了接受重复健康检查的参与者(n = 1,708,103)。蛋白尿的存在通过尿试纸分析结果确定。结局是AF的发生(国际疾病分类-10代码:I48)。:所有纳入的参与者,分别有1,666,111(97.5%)、17,659(1.0%)、19,696(1.2%)和4,637(0.3%)被分为无蛋白尿、改善、进展和持续组。在中位随访14.5年期间,发生了41,190例(2.4%)AF病例。在多变量分析中,蛋白尿改善组和蛋白尿持续组中,AF风险随着初始严重程度越严重而增加(趋势P < 0.001)。在进一步的两两比较中,与蛋白尿持续组相比,蛋白尿改善组的AF风险相对较低(HR:0.751,95%CI:0.652 - 0.865,P < 0.001)。:我们的研究表明,AF风险可根据蛋白尿状态的改变而变化。值得注意的是,从蛋白尿中恢复也可被视为AF的一个可改变的危险因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3624/11355726/13e9626fd02b/jcm-13-04648-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验